1)- Olga Bodriagova, Rebecca Ann Previs, Lydia Gaba, Abhishek Shankar, Laura Vidal, Kamal S Saini. Recent Advances in Gynecological Malignancies: Focus on ASCO 2023.Oncology and therapy. 2023, 11 (4): 397-409
2)- Brian Dong, Rita Lusen, Ella Chick, Lisa Kline. Shared Decision-Making on Using a CDK4/6 Inhibitor plus an Aromatase Inhibitor for HR+/HER2- Metastatic Breast Cancer: A Podcast.Oncology and therapy. 2023, 11 (4): 411-418
3)- Stephen V Liu, Ivy B Elkins, Jill Feldman, Sarah B Goldberg. EGFR Mutations Are Not All the Same: the Importance of Biomarker Testing in Non-small Cell Lung Cancer (NSCLC)-A Podcast Discussion Between Patients and Oncologists.Oncology and therapy. 2023, 11 (4): 419-431
5)- Hamdy A Azim, Samah A Loutfy, Hatem A Azim, Nermin S Kamal, Nasra F Abdel Fattah, Mostafa H Elberry, Mohamed R Abdelaziz, Marwa Abdelsalam, Madonna Aziz, Kyrillus S Shohdy, Loay Kassem. The Landscape of BRCA Mutations among Egyptian Women with Breast Cancer.Oncology and therapy. 2023, 11 (4): 445-459
6)- Karthik Nagaraja Rao, Ripudaman Arora, Prajwal Dange, Nitin Nagarkar, Antti A Mäkitie, Luiz P Kowalski, Avraham Eisbruch, Marc Hamoir, Francisco J Civantos, Vincent Vander Poorten, Sweet Ping Ng, Sandra Nuyts, Mark Zafereo, Ameya A Asarkar, Paweł Golusinski, Ohad Ronen, Alfio Ferlito. A Meta-analysis of Surgical Outcomes of T4a and Infranotch T4b Oral Cancers.Oncology and therapy. 2023, 11 (4): 461-480
7)- Sandhya Mehta, Jipan Xie, Raluca Ionescu-Ittu, Xiaoyu Nie, Winghan J Kwong. Real-World Treatment Patterns and Outcomes Following First-Line Pertuzumab and Trastuzumab Among Patients with HER2+ Metastatic Breast Cancer.Oncology and therapy. 2023, 11 (4): 481-493
8)- Javier Sanchez Alvarez, Mahmoud Jaber, Marie-Hélène Blanchet Zumofen. Multiple Real-World Data Sources in a Bayesian Framework to Inform Long-Term Survival Estimates of Mosunetuzumab in Patients with Follicular Lymphoma.Oncology and therapy. 2023, 11 (4): 495-511
9)- Naama Halpern, Ben Boursi, Einat Shacham-Shmueli, Einav Nili Gal-Yam, Ofer Margalit, Talia Golan, Tamar Beller, Gal Strauss, Dafna Yahav, Eyal Leshem. Early Systemic Anti-neoplastic Treatment Post SARS-CoV-2 Infection in Patients with Breast Cancer.Oncology and therapy. 2023, 11 (4): 513-519